EGFR and non-small cell lung carcinoma: Hojbjerg et al. [99] investigated the predictive value of four miRNAs (miR-30b, miR-30c, miR-221, and miR-222) in the plasma of epidermal growth factor receptor (EGFR)-mutated NSCLC patients receiving erlotinib.